Breast cancer targeted drugs obstruct the growth of cancer through interfering with the function of specific molecules that are responsible for cancer cell proliferation, survival, migration, invasion, metastasis, apoptosis, cell-cycle progression, angiogenesis and other vital cell cycle pathways. With the latest developments in molecular biology and immunotherapy, tailoring personalized therapies have been tailored to the specific pathophysiology of different types of breast cancers.
You must log in or register a new account in order to contact the publisher